Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib + Letrozole in Advanced HR+ Breast Cancer
NCT00263198Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2006
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in Hormone-Receptor-Positive Breast Cancer, sponsored by Washington University School of Medicine. Started Mar 2006; status: terminated.
02
Drugs
vatalanib
03
Conditions
Hormone-Receptor-Positive Breast Cancer
Beyond the preview
Go deeper on NCT00263198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263198.